Company news
Surrozen, Inc. news in 2025
Surrozen, Inc.'s news releases, calls and decks from 2025, newest first.
Surrozen to Present at Upcoming Healthcare Investor Conferences
November 25, 2025
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 12, 2025
Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update
November 7, 2025
Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 4, 2025
Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update
August 8, 2025
Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway
May 14, 2025
Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update
May 9, 2025
Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates
March 31, 2025
Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases
March 24, 2025